» Articles » PMID: 11104774

ADP is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Dec 6
PMID 11104774
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

P2Y receptors are a class of G protein-coupled receptors activated primarily by ATP, UTP, and UDP. Five mammalian P2Y receptors have been cloned so far including P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11. P2Y1, P2Y2, and P2Y6 couple to the activation of phospholipase C, whereas P2Y4 and P2Y11 couple to the activation of both phospholipase C and the adenylyl cyclase pathways. Additional ADP receptors linked to Galpha(i) have been described but have not yet been cloned. SP1999 is an orphan G protein-coupled receptor, which is highly expressed in brain, spinal cord, and blood platelets. In the present study, we demonstrate that SP1999 is a Galpha(i)-coupled receptor that is potently activated by ADP. In an effort to identify ligands for SP1999, fractionated rat spinal cord extracts were assayed for Ca(2+) mobilization activity against Chinese hamster ovary cells transiently transfected with SP1999 and chimeric Galpha subunits (Galpha(q/i)). A substance that selectively activated SP1999-transfected cells was identified and purified through a series of chromatographic steps. Mass spectral analysis of the purified material definitively identified it as ADP. ADP was subsequently shown to inhibit forskolin-stimulated adenylyl cyclase activity through selective activation of SP1999 with an EC(50) of 60 nM. Other nucleotides were able to activate SP1999 with a rank order of potency 2-MeS-ATP = 2-MeS-ADP > ADP = adenosine 5'-O-2-(thio)diphosphate > 2-Cl-ATP > adenosine 5'-O-(thiotriphosphate). Thus, SP1999 is a novel, Galpha(i)-linked receptor for ADP.

Citing Articles

Role and recent progress of P2Y12 receptor in cancer development.

Xi Y, Min Z, Liu M, Lin X, Yuan Z Purinergic Signal. 2024; .

PMID: 38874752 DOI: 10.1007/s11302-024-10027-w.


Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model.

Saito K, Shigetomi E, Shinozaki Y, Kobayashi K, Parajuli B, Kubota Y Brain. 2023; 147(2):698-716.

PMID: 37955589 PMC: 10834242. DOI: 10.1093/brain/awad358.


Pharmacological characterization of P2Y receptor subtypes - an update.

von Kugelgen I Purinergic Signal. 2023; 20(2):99-108.

PMID: 37697211 PMC: 10997570. DOI: 10.1007/s11302-023-09963-w.


Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats.

Miguel-Martinez A, Linares-Bedolla J, Villanueva-Castillo B, Haanes K, MaassenVanDenBrink A, Villalon C Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986572 PMC: 10056196. DOI: 10.3390/ph16030475.


GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12.

Zhao X, Cooper M, Michael J, Yarman Y, Baltz A, Chuprun J Blood Adv. 2022; 6(15):4524-4536.

PMID: 35793439 PMC: 9636328. DOI: 10.1182/bloodadvances.2022007007.